Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Gut microbiome, metabolome, host immunity associated with inflammatory bowel disease and intervention of fecal microbiota transplantation
Rongrong Wu, Rui Xiong, Yan Li, et al.
Journal of Autoimmunity (2023) Vol. 141, pp. 103062-103062
Closed Access | Times Cited: 58

Showing 1-25 of 58 citing articles:

Fecal microbiota transplantation: current challenges and future landscapes
Abbas Yadegar, Haggai Bar‐Yoseph, Tanya Monaghan, et al.
Clinical Microbiology Reviews (2024) Vol. 37, Iss. 2
Open Access | Times Cited: 29
Surviving Sepsis Campaign Research Priorities 2023
Daniel De Backer, Clifford S. Deutschman, Judith Hellman, et al.
Critical Care Medicine (2024) Vol. 52, Iss. 2, pp. 268-296
Open Access | Times Cited: 26
Gut microbiota regulates gut homeostasis, mucosal immunity and influences immune-related diseases
Guoao Ding, Xuezhi Yang, Ying Li, et al.
Molecular and Cellular Biochemistry (2024)
Closed Access | Times Cited: 14
Curcumin in inflammatory bowel diseases: Cellular targets and molecular mechanisms
Amylly Sanuelly da Paz Martins, MARLA DE CERQUEIRA ALVES, Orlando Roberto Pimentel de Araújo, et al.
Biocell (2023) Vol. 47, Iss. 11, pp. 2547-2566
Open Access | Times Cited: 28
Global, regional, and national burden of inflammatory bowel disease, 1990–2021: Insights from the global burden of disease 2021
Dao-po Lin, Jin Yang, Xiaoxiao Shao, et al.
International Journal of Colorectal Disease (2024) Vol. 39, Iss. 1
Open Access | Times Cited: 9
Inhibiting the cGAS-STING Pathway in Ulcerative Colitis with Programmable Micelles
Saji Uthaman, Shadi Parvinroo, Ansuja Pulickal Mathew, et al.
ACS Nano (2024) Vol. 18, Iss. 19, pp. 12117-12133
Closed Access | Times Cited: 7
Functional fractions of Astragalus polysaccharides as a potential prebiotic to alleviate ulcerative colitis
Zeqi Huo, Junxiang Li, Xiaofeng Li, et al.
International Journal of Biological Macromolecules (2024) Vol. 271, pp. 132580-132580
Closed Access | Times Cited: 7
Lactobacillus acidophilus and its metabolite ursodeoxycholic acid ameliorate ulcerative colitis by promoting Treg differentiation and inhibiting M1 macrophage polarization
Song Deng, Chaoying Pei, Kaiwei Cai, et al.
Frontiers in Microbiology (2024) Vol. 15
Open Access | Times Cited: 6
Bacteroides thetaiotaomicron and Faecalibacterium prausnitzii served as key components of fecal microbiota transplantation to alleviate colitis
Binqiang Xu, Yang Fu, Nuoming Yin, et al.
AJP Gastrointestinal and Liver Physiology (2024) Vol. 326, Iss. 5, pp. G607-G621
Closed Access | Times Cited: 6
A systematic framework for understanding the microbiome in human health and disease: from basic principles to clinical translation
Ziqi Ma, Tao Zuo, Norbert Frey, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 5
Dietary content and eating behavior in ulcerative colitis: a narrative review and future perspective
Lun‐Xiu Qin, Wenliang Lv
Nutrition Journal (2025) Vol. 24, Iss. 1
Open Access
Microbiome characterization of patients with Crohn disease and the use of fecal microbiota transplantation: A review
Shiju Chen, Daya Zhang, Da Li, et al.
Medicine (2025) Vol. 104, Iss. 4, pp. e41262-e41262
Open Access
L-Theanine prevents ulcerative colitis by regulating the CD4+ T cell immune response through the gut microbiota and its metabolites
Wei Xu, Ao-Xiang Liu, Zhihua Gong, et al.
The Journal of Nutritional Biochemistry (2025), pp. 109845-109845
Closed Access
Research progress on edible mushroom polysaccharides as a novel therapeutic strategy for inflammatory bowel disease
Yating Song, Yuqin Feng, Guishan Liu, et al.
International Journal of Biological Macromolecules (2025), pp. 140994-140994
Closed Access
Changes in gut microbiota of hyperthyroidism rats and the intervention effect of Radix Scrophulariae based on fecal metabolomics and 16S rRNA gene sequencing analysis
Ning Zhang, Shumin Liu, Zihui Li, et al.
Heliyon (2025), pp. e42689-e42689
Open Access
Fecal microbiota transplantation restores gut microbiota diversity in children with active Crohn’s disease: a prospective trial
Biao Zou, Shengxuan Liu, Chen Dong, et al.
Journal of Translational Medicine (2025) Vol. 23, Iss. 1
Open Access
Amorphous silica nanoparticles and the human gut microbiota: a relationship with multiple implications
Massimiliano G. Bianchi, Martina Chiu, Giuseppe Taurino, et al.
Journal of Nanobiotechnology (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 4
Polysaccharides from Lycium barbarum, yam, and sunflower ameliorate colitis in a structure and intrinsic flora-dependent manner
Shanshan Zhang, Ruchen Zhou, Xiaoran Xie, et al.
Carbohydrate Polymers (2024) Vol. 349, pp. 122905-122905
Closed Access | Times Cited: 4
Sterile Fecal Microbiota Transplantation Boosts Anti-Inflammatory T-Cell Response in Ulcerative Colitis Patients
А. В. Чечушков, Pavel Desyukevich, Timir Yakovlev, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 3, pp. 1886-1886
Open Access | Times Cited: 3
Enteric Nervous System Alterations in Inflammatory Bowel Disease: Perspectives and Implications
Shubhankar Suman
Gastrointestinal Disorders (2024) Vol. 6, Iss. 2, pp. 368-379
Open Access | Times Cited: 3
Astragalus polysaccharides alleviate DSS-induced ulcerative colitis in mice by restoring SCFA production and regulating Th17/Treg cell homeostasis in a microbiota-dependent manner
Yu Zhang, Wenting Ji, Hailong Qin, et al.
Carbohydrate Polymers (2024) Vol. 349, pp. 122829-122829
Closed Access | Times Cited: 3
The Usefulness of Resistant Maltodextrin and Chitosan Oligosaccharide in Management of Gut Leakage and Microbiota in Chronic Kidney Disease
Weerapat Anegkamol, Panumas Kamkang, Sittiphong Hunthai, et al.
Nutrients (2023) Vol. 15, Iss. 15, pp. 3363-3363
Open Access | Times Cited: 8
Alterations in Gut Microbiota as Early Biomarkers for Predicting Inflammatory Bowel Disease Onset and Progression: A Systematic Review
Kusalik Boppana, Naiela E Almansouri, Saloni Bakkannavar, et al.
Cureus (2024)
Open Access | Times Cited: 2
Dietary supplementation with non-digestible isomaltooligosaccharide and Lactiplantibacillus plantarum ZDY2013 ameliorates DSS-induced colitis via modulating intestinal barrier integrity and the gut microbiota
Zhihong Zhang, Yingsheng Hu, Na Zhang, et al.
Food & Function (2024) Vol. 15, Iss. 11, pp. 5908-5920
Closed Access | Times Cited: 2
Zinc and Inflammatory Bowel Disease: From Clinical Study to Animal Experiment
Xi Peng, Yingxiang Yang, Rao Zhong, et al.
Biological Trace Element Research (2024)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top